Harbor Capital Advisors Inc. Makes New $70,000 Investment in National Health Investors, Inc. (NYSE:NHI)

Harbor Capital Advisors Inc. purchased a new stake in National Health Investors, Inc. (NYSE:NHIFree Report) during the third quarter, HoldingsChannel reports. The institutional investor purchased 827 shares of the real estate investment trust’s stock, valued at approximately $70,000.

Several other institutional investors and hedge funds also recently modified their holdings of NHI. Arizona State Retirement System lifted its stake in National Health Investors by 1.9% in the 2nd quarter. Arizona State Retirement System now owns 12,152 shares of the real estate investment trust’s stock valued at $823,000 after acquiring an additional 222 shares in the last quarter. Van ECK Associates Corp raised its holdings in shares of National Health Investors by 6.9% in the second quarter. Van ECK Associates Corp now owns 6,404 shares of the real estate investment trust’s stock valued at $434,000 after purchasing an additional 416 shares during the last quarter. International Assets Investment Management LLC bought a new stake in shares of National Health Investors in the second quarter worth $36,000. USA Financial Formulas boosted its holdings in National Health Investors by 172.8% during the third quarter. USA Financial Formulas now owns 922 shares of the real estate investment trust’s stock worth $78,000 after purchasing an additional 584 shares during the last quarter. Finally, ProShare Advisors LLC grew its position in National Health Investors by 8.5% in the first quarter. ProShare Advisors LLC now owns 7,506 shares of the real estate investment trust’s stock valued at $472,000 after purchasing an additional 591 shares in the last quarter. 62.51% of the stock is owned by institutional investors and hedge funds.

National Health Investors Price Performance

NYSE:NHI opened at $81.19 on Friday. National Health Investors, Inc. has a 12-month low of $50.12 and a 12-month high of $86.13. The firm has a market capitalization of $3.69 billion, a price-to-earnings ratio of 27.90, a P/E/G ratio of 5.16 and a beta of 1.05. The stock’s 50 day moving average price is $80.36 and its two-hundred day moving average price is $73.34. The company has a quick ratio of 10.27, a current ratio of 10.29 and a debt-to-equity ratio of 0.92.

National Health Investors (NYSE:NHIGet Free Report) last posted its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42). National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The business had revenue of $63.32 million during the quarter, compared to the consensus estimate of $67.93 million. During the same quarter last year, the company posted $1.08 EPS. The firm’s revenue was up 1.7% on a year-over-year basis. On average, analysts anticipate that National Health Investors, Inc. will post 4.44 earnings per share for the current year.

National Health Investors Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 29th. Investors of record on Tuesday, December 31st will be issued a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a dividend yield of 4.43%. The ex-dividend date is Tuesday, December 31st. National Health Investors’s payout ratio is 123.71%.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on NHI shares. Wells Fargo & Company cut shares of National Health Investors from an “overweight” rating to an “equal weight” rating and boosted their price target for the stock from $81.00 to $86.00 in a research report on Tuesday, October 1st. Bank of America started coverage on National Health Investors in a report on Tuesday, September 24th. They set a “buy” rating and a $92.00 target price on the stock. StockNews.com cut National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th. Finally, Truist Financial boosted their price target on National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a research report on Friday, August 30th. Four analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $73.29.

Read Our Latest Report on National Health Investors

National Health Investors Profile

(Free Report)

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

See Also

Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors, Inc. (NYSE:NHIFree Report).

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.